What is the LSX Congress USA?
VP, Venture Science, Eli Lilly
Senior VP, Baxter
SVP, Head Corporate Development, Novo Nordisk
General Partner, Canaan Partners
VP, Strategy & BD (M&A), Specialty Diagnostics Group, Thermofisher
Founder & CEO, Akili Interactive
VP & Head, Takeda Business Development
EVP, CBO, Ipsen
MD, Perceptive Advisors
Venture Partner, Takeda Digital Ventures
CEO & Partner, Flagship Pioneering
Managing Partner, Forbion
Director, Foresite Capital
VP of Corporate Development, Smith & Nephew
Partner, Bain Capital Life Sciences
5 reasons to choose LSX USA
LSX USA focuses almost exclusively on 3 main profiles – executives of life science and healthcare innovators (Biotech, Medtech and Healthtech), investors an large pharma/medtech. That means our delegation is extremely focussed, extremely relevant and perfectly matched for partnering and investment.
Meet the partners
I had the pleasure to participate in a great session. A unique opportunity for companies, big and small.
Our engagement with LSX has evolved into a trusted partnership which helps us connect with innovative and exciting companies in Europe and the US.
LSX creates a hugely meaningful forum for educating and networking with healthcare entrepreneurs.
Watch the LSX USA 2023 intro video